![Gene Mack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gene Mack
Chief Executive Officer at
GAIN THERAPEUTICS, INC.
Net worth: 28 080 $ as of 2026-05-30
Profile
Gene C.
Mack is President, Chief Executive Officer & Director at Gain Therapeutics, Inc. starting in 2025.
Former positions include Executive Director at Mizuho Securities USA LLC (2011), Senior Director-Finance & Investor Relations at Edge Therapeutics, Inc. (2013–2015), Managing Director at Brean Capital LLC (2012–2014), Chief Financial Officer & Treasurer at SELLAS Life Sciences Group, Inc. (2018), Chief Financial Officer & Senior Vice President at Ascendia Pharmaceuticals, Inc. (2015–2017), Chief Financial Officer at ImCyse SA (2021–2023), Research Analyst at Soleil Securities Corp.
(2009–2011), Analyst at HSBC Securities (USA), Inc. (2007), Analyst at Ryan, Beck & Co., Inc. (2004), Research Analyst at FM Partners Holdings LLC (2008–2009), and Chief Financial Officer at OncoC4, Inc. Education includes undergraduate and MBAistration degrees from Fordham University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-26 | 14,400 ( 0.03% ) | 28 080 $ | 2026-05-30 |
Gene Mack active positions
| Companies | Position | Start |
|---|---|---|
| GAIN THERAPEUTICS, INC. | Chief Executive Officer | 2024-06-24 |
Former positions of Gene Mack
| Companies | Position | End |
|---|---|---|
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Director of Finance/CFO | 2023-09-30 |
| SELLAS LIFE SCIENCES GROUP, INC. | Director of Finance/CFO | 2018-12-16 |
Ascendia Pharmaceuticals, Inc.
 Ascendia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical contract formulation development and manufacturing organization | Director of Finance/CFO | 2016-12-31 |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Investor Relations Contact | 2014-12-31 |
Brean Capital LLC
 Brean Capital LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2014-02-28 |
Training of Gene Mack
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
74
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Ryan, Beck & Co., Inc.
 Ryan, Beck & Co., Inc. Investment Banks/BrokersFinance Provides brokerage and investment banking services | Finance |
Soleil Securities Corp.
 Soleil Securities Corp. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Mizuho Securities USA LLC
 Mizuho Securities USA LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
HSBC Securities (USA), Inc.
 HSBC Securities (USA), Inc. Regional BanksFinance Provides banking and financial services | Finance |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Health Technology |
FM Partners Holdings LLC
 FM Partners Holdings LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Gruntal & Co. LLC
 Gruntal & Co. LLC General GovernmentGovernment Provides financial services | Government |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brean Capital LLC
Brean Capital LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Health Technology |
SELLAS Life Sciences Group, Inc.
 SELLAS Life Sciences Group, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Ascendia Pharmaceuticals, Inc.
Ascendia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical contract formulation development and manufacturing organization | Health Technology |
Gain Therapeutics, Inc.
 Gain Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Oncoc4, Inc.
 Oncoc4, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines for cancer | Health Technology |
- Stock Market
- Insiders
- Gene Mack
